• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Coherus`s Loqtorzi (toripalimab) Receives Approval in Europe

    EMA

    Coherus Biosciences` Loqtorzi (toripalimab) Receives Suppl. Approval in the U.S.

    FDA

    Coherus Biosciences` Biologic Loqtorzi (toripalimab) Receives Approval in the U.S.

    FDA

    Coherus` Biologic Yusimry (Adalimumab) Receives Approval in the U.S.

    FDA

    Coherus`s Biologic Yusimry ( Adalimumab) Receives Approval in the U.S.

    FDA

    Coherus` Biologic Udenyca ( Pegfilgrastim) Receives Approval in the U.S.

    FDA

    Coherus` Biologic Udenyca (Pegfilgrastim) Receives Approval in the U.S.

    FDA

    Coherus Biosciences Cimerli (ranibizumab-eqrn) Receives BLA Approval in the U.S.

    FDA

    Coherus Biosciences Inc`s Biological Pegfilgrastim-Cbqv Receives Approval In US

    FDA

    Coherus Biosciences Udenyca (Pegfilgrastim-Cbqv) Receives Approval in US

    FDA

    Coherus Biosciences`s Udenyca (Pegfilgrastim-Cbqv)Receives Supplemental Approval in US

    FDA

    Coherus Biosciences` Biological Pegfilgrastim-Cbqv Receives Approval in US

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.